PRESENTATION TITLE
Overview Of Clinical Use Of Neutron Therapy In The U.S.

PRESENTER(S)

George E. Laramore, Ph.D., M.D.

Peter Wootton Professor of Radiation Oncology

PRESENTER BIO
Dr. Laramore received a PhD in theoretical physics from the University of Illinois in 1969 and then became a faculty member of the many body group before moving to Sandia Laboratories where he was involved in surface physics research.  He became interested in biological systems through work in surface catalysis and then went to medical school at the University of Miami, receiving his MD in 1976.  He undertook residency training in Radiation Oncology at the University of Washington and was appointed a member of the faculty while completing training.  His research is largely the interface area between physics and medicine with a particular interest in the biological properties and applications of high linear energy transfer (LET) radiation to cancer treatment.  He has worked with fast neutron radiotherapy since the mid-1970s and with neutron capture therapy modeling since the mid-1990s.  He has also been involved in the modeling of the properties of alpha particle emitters such as ²¹¹At which offer the possibility of treating tumors in situations where binding sites are small in absolute number but for which highly specific targeting agents can be developed.  He has been the principal investigator for numerous clinical trials and currently serves as the University of Washington institutional P.I. for the Radiation Therapy Oncology Group which has now become the National Research Group.  He was department chair between 1997 and 2013 and during this period helped to develop a proton radiotherapy center in the Pacific Northwest. He is the institutional P.I. for the Proton Collaborative Group which conducts clinical trials at our new proton facility and serves on the Board of Directors for the Proton Cooperative Group.

VIEWING LOCATIONS 

 Zoom (Live)

LEARNING OBJECTIVES

• Describe the biological underpinnings of neutron therapy and compare and contrast with photons and protons.
• Outline the role of neutron therapy in the treatment of a spectrum of malignancies.

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

QUESTIONS?
Contact Coordinator Name Harrell.anna@mayo.edu or Grissett.victoria@mayo.edu
 
LOCATION: 
Mayo Clinic Florida

4500 San Pablo Rd

Jacksonville FL 32224


SUPPORT LOCATION: 
Florida